Investor Presentaiton
SKAN's investment highlights
1
Market leader globally for
high-end aseptic process
solutions catering the global
biopharma industry
2
Technology & innovation
3
leadership with first-to-
market solutions and
reference point for aseptic
manufacturing guidelines
xan
Strategically positioned in a
highly dynamic & rapidly
growing niche market
driven by strong underlying
end market growth
4 Significant barriers to
entry due to regulatory
requirements know-how and
mission criticality of aseptic
processes
5
Trusted, long-term partner
6
Experienced &
7
Excellent financial profile
8
to a large, diversified
entrepreneurial
with demonstrated profitable
customer base including
almost all major blue-chip
(bio-)pharma companies
management with proven
track record of organic
growth
above-market growth and
solid revenue visibility
November 2023
SKAN Group AG Investor Presentation
Clear strategy with multiple
avenues for growth and
expansion of addressable
market
5
SKANView entire presentation